Transmission Electron Microscopy (TEM) |
In vitro |
Vacuoles containing cytoplasmic contents (autophagosomes or autolysosomes) |
Difficult to quantify using unbiased method. Variability in cell areas sampled. |
[55] |
Detection of LC3-I and LC3-II |
In vitro |
Increased band intensity of LC3-II and increased ratio of LC3-II over LC3-I |
Difficult to distinguish between upregulation of autophagosome formation or blockage of autophagic degradation without using lysosomal inhibitors. |
[55] |
|
|
|
|
[56] |
|
|
|
|
[57] |
|
|
|
|
[58] |
Detection of LC3-II and p62 in presence of chloroquine |
In vitro |
Lower LC3-II and higher p62 accumulation |
Changes in p62 levels can be specific to cell-type and context being studied. |
[47] |
|
|
|
|
[50] |
p62 sequestosome/degradation assay |
In vitro |
Accumulation of p62 in presence of proteasome inhibitor |
Not always a correlation between increase in autophagy and decrease in P62 levels. |
[57, 58] |
LC3 immunofluorescence |
In vitro |
Reduced in number of LC3 puncta |
Not all LC3 puncta represent LC3-II and correspond to autophagosomes. |
[50] |
GFP-LC3 puncta |
In vitro |
Increase in number of GFP-LC3 puncta |
High levels of GFP-LC3 can associate with ubiquitinated aggregates to lead to misinterpretation about the number of autophagic structures. Reflects only a snapshot of the numbers of autophagy-related structures. |
[56] |
GFP-LC3 transgenic mice and detection of LC3-II in presence of chloroquine |
In vitro and in vivo
|
Phenotype cells expressing GFP-LC3 puncta. Lower LC3-II accumulation |
GFP-LC3 expression driven by CAG promoter, thus intensity of the GFP signal may represent CAG promoter activity, not autophagic activity. |
[49] |
mRFP-GFP-LC3 tandem construct |
In vitro |
Increases in percentage of mRFP-only positive LC3 puncta. |
Colocalization of GFP and mRFP might be seen in the case of impaired proteolytic degradation within autolysosomes, or altered lysosomal pH |
[58] |
mCherry-EGFP-LC3 retrovirus |
In vivo |
mCherry+ puncta (autolysosomes) around cell body. |
Difficult to distinguish between reduced autophagosome production or enhanced autolysosomal degradation without using lysosomal inhibitors. |
[40] |